ro 22-3581 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Craven, PA; DeRubertis, FR | 1 |
| Sullivan, AC; Triscari, J | 1 |
2 other study(ies) available for ro 22-3581 and Alloxan Diabetes
| Article | Year |
|---|---|
Suppression of urinary albumin excretion in diabetic rats by 4'(imidazol-1-yl) acetophenone, a selective inhibitor of thromboxane synthesis.
Topics: Albuminuria; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dinoprostone; Female; Glomerular Filtration Rate; Imidazoles; Proteinuria; Rats; Rats, Inbred Strains; Reference Values; Serum Albumin; Thromboxane B2; Thromboxanes | 1990 |
A pharmacotherapeutic approach to the regulation of hyperinsulinemia and obesity.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Imidazoles; Insulin; Obesity; Rats; Rats, Zucker; Thromboxane B2; Thromboxane-A Synthase | 1987 |